These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 28762948)
1. Previous Atorvastatin Treatment and Risk of Diabetic Foot Infection in Adult Patients: A Case-control Study. Nassaji M; Ghorbani R; Saboori Shkofte H Wounds; 2017 Jul; 29(7):196-201. PubMed ID: 28762948 [TBL] [Abstract][Full Text] [Related]
2. Are antibiotic-resistant pathogens more common in subsequent episodes of diabetic foot infection? Lebowitz D; Gariani K; Kressmann B; Dach EV; Huttner B; Bartolone P; Lê N; Mohamad M; Lipsky BA; Uçkay I Int J Infect Dis; 2017 Jun; 59():61-64. PubMed ID: 28450198 [TBL] [Abstract][Full Text] [Related]
3. Do diabetic foot infections with methicillin-resistant Staphylococcus aureus differ from those with other pathogens? Zenelaj B; Bouvet C; Lipsky BA; Uçkay I Int J Low Extrem Wounds; 2014 Dec; 13(4):263-72. PubMed ID: 25288579 [TBL] [Abstract][Full Text] [Related]
4. Retrospective cohort study evaluating the incidence of diabetic foot infections among hospitalized adults with diabetes in the United States from 1996-2010. Duhon BM; Hand EO; Howell CK; Reveles KR Am J Infect Control; 2016 Feb; 44(2):199-202. PubMed ID: 26541067 [TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Infection with Pseudomonas aeruginosa in Diabetic Foot Infections. Ertugrul BM; Lipsky BA; Ture M; Sakarya S J Am Podiatr Med Assoc; 2017 Nov; 107(6):483-489. PubMed ID: 29252023 [TBL] [Abstract][Full Text] [Related]
6. Methicillin-resistant Staphylococcus aureus infection epidemiology and clinical response from tigecycline soft tissue infection trials. Puzniak LA; Quintana A; Wible M; Babinchak T; McGovern PC Diagn Microbiol Infect Dis; 2014 Jun; 79(2):261-5. PubMed ID: 24725736 [TBL] [Abstract][Full Text] [Related]
7. Empirical Antibiotic Treatment in Diabetic Foot Infection: A Study Focusing on the Culture and Antibiotic Sensitivity in a Population From Southern China. Wu WX; Liu D; Wang YW; Wang C; Yang C; Liu XZ; Mai LF; Ren M; Yan L Int J Low Extrem Wounds; 2017 Sep; 16(3):173-182. PubMed ID: 28836481 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Cost-Effectiveness, Safety, and Efficacy of Rosuvastatin Versus Atorvastatin, Pravastatin, and Simvastatin in Dyslipidemic Diabetic Patients With or Without Metabolic Syndrome. Bener A; Dogan M; Barakat L; Al-Hamaq AO J Prim Care Community Health; 2014 Jul; 5(3):180-7. PubMed ID: 24522932 [TBL] [Abstract][Full Text] [Related]
9. Comparative effects of cholesteryl ester transfer protein inhibition, statin or ezetimibe on lipid factors: The ACCENTUATE trial. Nicholls SJ; Ray KK; Ballantyne CM; Beacham LA; Miller DL; Ruotolo G; Nissen SE; Riesmeyer JS; Atherosclerosis; 2017 Jun; 261():12-18. PubMed ID: 28412650 [TBL] [Abstract][Full Text] [Related]
10. Diabetic Foot Infection in Morocco: Microbiological Profile. Belefquih B; Frikh M; Benlahlou Y; Maleh A; Jadid L; Bssaibis F; Ghazouani M; Chagar B; Lamsaouri J; Lemnouer A; Elouennass M Wounds; 2016 Mar; 28(3):89-98. PubMed ID: 26978862 [TBL] [Abstract][Full Text] [Related]
11. Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial. Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H; J Am Coll Cardiol; 2015 Aug; 66(5):495-507. PubMed ID: 26227186 [TBL] [Abstract][Full Text] [Related]
12. Daptomycin for methicillin-resistant Staphylococcus aureus diabetic foot infections. Joseph WS; Quast T; Cogo A; Crompton MG; Yoon MJ; Lamp KC; Culshaw D; Chaves RL J Am Podiatr Med Assoc; 2014 Mar; 104(2):159-68. PubMed ID: 24725036 [TBL] [Abstract][Full Text] [Related]
13. A Retrospective Analysis of Microbiologic Profile of Foot Infections in Patients With Diabetic End-Stage Renal Disease. Körpinar Ş Int J Low Extrem Wounds; 2021 Mar; 20(1):15-21. PubMed ID: 32940096 [TBL] [Abstract][Full Text] [Related]
14. [Risk factors for infections of methicillin-resistant Staphylococci in diabetic foot patients]. Ding Q; Li DQ; Wang PH; Chu YJ; Meng SY; Sun Q Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(4):228-31. PubMed ID: 22490791 [TBL] [Abstract][Full Text] [Related]
15. Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial. Kimura G; Kasahara M; Ueshima K; Tanaka S; Yasuno S; Fujimoto A; Sato T; Imamoto M; Kosugi S; Nakao K Clin Exp Nephrol; 2017 Jun; 21(3):417-424. PubMed ID: 27392909 [TBL] [Abstract][Full Text] [Related]
16. Association of bacteria in diabetic and non-diabetic foot infection - An investigation in patients from Bangladesh. Karmaker M; Sanyal SK; Sultana M; Hossain MA J Infect Public Health; 2016; 9(3):267-77. PubMed ID: 26617249 [TBL] [Abstract][Full Text] [Related]
18. Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate. Lipsky BA; Giordano P; Choudhri S; Song J J Antimicrob Chemother; 2007 Aug; 60(2):370-6. PubMed ID: 17553812 [TBL] [Abstract][Full Text] [Related]
19. The Effect of Statins Use on the Risk and Outcome of Acute Bacterial Infections in Adult Patients. Nassaji M; Ghorbani R; Afshar RK J Clin Diagn Res; 2015 Nov; 9(11):OC09-12. PubMed ID: 26676277 [TBL] [Abstract][Full Text] [Related]
20. Link between nasal carriage of Staphylococcus aureus and infected diabetic foot ulcers. Dunyach-Remy C; Courtais-Coulon C; DeMattei C; Jourdan N; Schuldiner S; Sultan A; Carrière C; Alonso S; Sotto A; Lavigne JP Diabetes Metab; 2017 Apr; 43(2):167-171. PubMed ID: 27720361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]